These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37080137)

  • 21. Apparent clearance of valproic acid in elderly epileptic patients: estimation of the confounding effect of albumin concentration.
    Lampon N; Tutor JC
    Ups J Med Sci; 2012 Mar; 117(1):41-6. PubMed ID: 22206465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: a protein binding model.
    Gu X; Zhu M; Sheng C; Yu S; Peng Q; Ma M; Hu Y; Li Z; Jiao Z; Zhou B
    Eur J Clin Pharmacol; 2021 Jul; 77(7):999-1009. PubMed ID: 33423079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy.
    Bondareva IB; Jelliffe RW; Andreeva OV; Bondareva KI
    J Clin Pharm Ther; 2011 Oct; 36(5):625-36. PubMed ID: 21062333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine].
    Hurkacz M; Wiela-Hojeńska A; Orzechowska-Juzwenko K; Kozik A; Unolt J
    Pol Merkur Lekarski; 2001 Dec; 11(66):480-3. PubMed ID: 11899842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a Simple and Rapid Method to Measure Free Fraction of Valproic Acid in Plasma Using Ultrafiltration and Ultra High Performance Liquid Chromatography-Mass Spectroscopy: Application to Therapeutic Drug Monitoring.
    Xu S; Chen Y; Zhao M; Zhao L
    Ther Drug Monit; 2017 Oct; 39(5):575-579. PubMed ID: 28700449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of unbound valproic acid in plasma using centrifugal ultrafiltration and gas chromatography:Application in TDM.
    Gu X; Yu S; Peng Q; Ma M; Hu Y; Zhou B
    Anal Biochem; 2020 Jan; 588():113475. PubMed ID: 31634440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of free serum valproate concentration: A prospective study in patients on divalproex sodium monotherapy.
    Nasreddine W; Dirani M; Atweh S; Makki A; Beydoun A
    Seizure; 2018 Jul; 59():24-27. PubMed ID: 29730272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic variability of valproate during pregnancy - Implications for the use of therapeutic drug monitoring.
    Johannessen Landmark C; Farmen AH; Burns ML; Baftiu A; Lossius MI; Johannessen SI; Tomson T
    Epilepsy Res; 2018 Mar; 141():31-37. PubMed ID: 29453075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of total and free valproic acid during monotherapy in infants.
    Herngren L; Lundberg B; Nergårdh A
    J Neurol; 1991 Sep; 238(6):315-9. PubMed ID: 1940980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Influencing Sodium Valproate Serum Concentrations in Patients with Epilepsy Based on Logistic Regression Analysis.
    Lan X; Mo K; Nong L; He Y; Sun Y
    Med Sci Monit; 2021 Nov; 27():e934275. PubMed ID: 34776507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacist impact on adherence of valproic acid therapy in pediatric patients with epilepsy using active education techniques.
    Ma M; Peng Q; Gu X; Hu Y; Sun S; Sheng Y; Wang P; Ma H; Zhou B
    Epilepsy Behav; 2019 Sep; 98(Pt A):14-18. PubMed ID: 31299527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe valproic acid intoxication: case study on the unbound fraction and the applicability of extracorporeal elimination.
    van den Broek MP; Sikma MA; Ververs TF; Meulenbelt J
    Eur J Emerg Med; 2009 Dec; 16(6):330-2. PubMed ID: 19424075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro changes in the proportion of protein-unbound-free propofol induced by valproate.
    Ishii-Maruhama M; Higuchi H; Nakanou M; Honda-Wakasugi Y; Yabuki-Kawase A; Maeda S; Miyawaki T
    J Anesth; 2018 Oct; 32(5):688-693. PubMed ID: 30062394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid.
    Minkova GD; Getova DP
    Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
    Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing pharmacokinetics-pharmacodynamics model of valproic acid syrup based on prediction of population pharmacokinetics parameter and seizure frequency in Indonesian pediatric epilepsy outpatients.
    Prawira Nata Nugraha IK; Purnamayanti A; Ngurah Made Suwarba IG; Parfati N
    J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):305-311. PubMed ID: 34214324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender- or age-related binding characteristics of valproic acid to serum proteins in adult patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yukawa E; Fujimura A
    Eur J Pharm Biopharm; 2001 Jul; 52(1):57-63. PubMed ID: 11438424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rapid and simple HPLC-MS/MS method for the simultaneous quantification of valproic acid and its five metabolites in human plasma and application to study pharmacokinetic interaction in Chinese epilepsy patients.
    Wen D; Chen Z; Yang C; Liu H; Li H; Chen J; Dai Q; Zhong G; Qin J; Ni G; Huang M; Zhou L; Wang X
    J Pharm Biomed Anal; 2018 Feb; 149():448-456. PubMed ID: 29169113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implications of serum protein binding in epileptic children during sodium valproate maintenance therapy.
    Yu HY
    Ther Drug Monit; 1984; 6(4):414-23. PubMed ID: 6440321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.